Niki BioSolutions, Inc. Accounts Payable and Accrued Liabilities
Niki BioSolutions, Inc. (NIKI) had Accounts Payable and Accrued Liabilities of $1.04 million as of 2023-06-30, per its 6-K filed 2023-12-22.
Discontinued › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2023-12-22
- 2023-06-30: Accounts Payable and Accrued Liabilities $1.04M.
- 2022-12-31: Accounts Payable and Accrued Liabilities $6.17M.
- 2022-06-30: Accounts Payable and Accrued Liabilities $4.84M.
- 2021-12-31: Accounts Payable and Accrued Liabilities $4.17M.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2023-06-30 | $1.04M 6-K · filed 2023-12-22 |
| 2022-12-31 | $6.17M 6-K · filed 2023-12-22 |
| 2022-06-30 | $4.84M 6-K · filed 2022-09-30 |
| 2021-12-31 | $4.17M 20-F · filed 2023-04-28 |
| 2021-06-30 | $3.54M 6-K · filed 2021-09-15 |
| 2020-12-31 | $3.24M 20-F/A · filed 2023-01-17 |
| 2020-06-30 | $2.50M 6-K · filed 2020-09-02 |
| 2019-12-31 | $2.59M 20-F · filed 2021-04-19 |
| 2018-12-31 | $1.25M 20-F · filed 2020-04-29 |
| 2017-12-31 | $653.35K 20-F · filed 2019-04-15 |